Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Pharmacia & Upjohn and Centocor to copromote Fragmin in unstable angina

March 8, 1999

Antithrombotic P2T antagonists in development at Astra

March 8, 1999

Randomized comparison of aspirin, aspirin + warfarin and aspirin + ticlopidine following stenting

March 5, 1999

Platelet aggregation inhibitors in development at SmithKline Beecham

March 4, 1999

FDA grants priority review to Boehringer Ingelheim's new stroke therapy

March 4, 1999

Vasoflux is superior to other anticoagulants due to its unique mechanism of action

March 3, 1999

Corvas reacquires rights to injectable anticoagulant from Schering-Plough

March 2, 1999

Emisphere Technologies updates oral heparin development program

March 2, 1999

European CPMP recommends approval of Integrilin for acute coronary syndrome

March 1, 1999

Merck & Co.'s new thrombin inhibitors

March 1, 1999

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...